Aktie A14V91 PURAPHARM CORPORATION LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen PuraPharm Corporation Limited

Aktien

A14V91

KYG7306Y1044

1498

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:17 07.05.2024 		% 5 Tage % 1. Jan.
0,76 HKD +1,33 % Intraday Chart für PuraPharm Corporation Limited +4,11 % -15,56 %
01.04. PuraPharm's Nettoverlust schrumpft im Jahr 2023; Umsatz fällt um 9% MT
28.03. PuraPharm Corporation Limited meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
PuraPharm's Net Loss Shrinks in 2023; Revenue Falls 9%
PuraPharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023
PuraPharm Corporation Limited Announces Cessation of Norimoto Hisayoshi as Executive Director
PuraPharm Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2023
PuraPharm Corporation Limited Announces Appointment of Leung Stephen Kwok Keung as Non-Executive Director
PuraPharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022
PuraPharm Grants Nearly 8 Million Options
Purapharm Swings to H1 Loss on Lower Sales
PuraPharm Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2022
Purapharm Corporation Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2022
Purapharm Corporation Limited Announces Retirement of Non-Executive Director
Purapharm Turns to Loss in 2021 on Impairment Loss of Goodwill; Shares Fall 4%
PuraPharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2021
Purapharm Forecasts Turn to Loss in 2021
PuraPharm Corporation Limited Provides Earnings Guidance for the Year Ending December 31, 2021
Purapharm Corporation Limited Announces Change of Headquarter And principal Place of Business in Hong Kong
Purapharm : Cancels Sale of Intellectual Property Assets to BAGI Research
PuraPharm : Books Higher Profit, Revenue in H1
Purapharm Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2021
PuraPharm : RESIGNATION OF CHIEF FINANCIAL OFFICER, CHANGE OF COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A14V91 Aktie
  4. Nachrichten PuraPharm Corporation Limited
  5. Andere Sprachen